These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 32875729)

  • 1. Potential monoamine oxidase A inhibitor suppressing paclitaxel-resistant non-small cell lung cancer metastasis and growth.
    Yang X; Zhao D; Li Y; Li Y; Cui W; Li Y; Li H; Li X; Wang D
    Thorac Cancer; 2020 Oct; 11(10):2858-2866. PubMed ID: 32875729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repurposing of a monoamine oxidase A inhibitor‑heptamethine carbocyanine dye conjugate for paclitaxel‑resistant non‑small cell lung cancer.
    Yang XG; Li YY; Zhao DX; Cui W; Li H; Li XY; Li YX; Wang D
    Oncol Rep; 2021 Mar; 45(3):1306-1314. PubMed ID: 33650669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of monoamine oxidase A in HPV-16 E7-induced epithelial-mesenchymal transition and HIF-1α protein accumulation in non-small cell lung cancer cells.
    Huang B; Zhou Z; Liu J; Wu X; Li X; He Q; Zhang P; Tang X
    Int J Biol Sci; 2020; 16(14):2692-2703. PubMed ID: 32792865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of miR-4262 in paclitaxel resistance through the regulation of PTEN in non-small cell lung cancer.
    Sun H; Zhou X; Bao Y; Xiong G; Cui Y; Zhou H
    Open Biol; 2019 Jul; 9(7):180227. PubMed ID: 31337279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-221-3p-mediated downregulation of MDM2 reverses the paclitaxel resistance of non-small cell lung cancer in vitro and in vivo.
    Ni L; Xu J; Zhao F; Dai X; Tao J; Pan J; Shi A; Shen Z; Su C; Zhang Y
    Eur J Pharmacol; 2021 May; 899():174054. PubMed ID: 33771522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emodin enhances antitumor effect of paclitaxel on human non-small-cell lung cancer cells in vitro and in vivo.
    Chen S; Zhang Z; Zhang J
    Drug Des Devel Ther; 2019; 13():1145-1153. PubMed ID: 31114158
    [No Abstract]   [Full Text] [Related]  

  • 7. Targeted paclitaxel-octreotide conjugates inhibited the growth of paclitaxel-resistant human non-small cell lung cancer A549 cells in vitro.
    Liu Y; Xia H; Wang Y; Han W; Qin J; Gao W; Qu X; Wang X
    Thorac Cancer; 2021 Nov; 12(22):3053-3061. PubMed ID: 34617400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Anti-Metastatic Potential of the Combination of Fisetin with Paclitaxel on A549 Non-Small Cell Lung Cancer Cells.
    Klimaszewska-Wiśniewska A; Hałas-Wiśniewska M; Grzanka A; Grzanka D
    Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of Paclitaxel and PXR Antagonist SPA70 Reverses Paclitaxel-Resistant Non-Small Cell Lung Cancer.
    Niu X; Wu T; Yin Q; Gu X; Li G; Zhou C; Ma M; Su L; Tang S; Tian Y; Yang M; Cui H
    Cells; 2022 Oct; 11(19):. PubMed ID: 36231056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rsf-1 Influences the Sensitivity of Non-Small Cell Lung Cancer to Paclitaxel by Regulating NF-κB Pathway and Its Downstream Proteins.
    Chen X; Sun X; Guan J; Gai J; Xing J; Fu L; Liu S; Shen F; Chen K; Li W; Han L; Li Q
    Cell Physiol Biochem; 2017; 44(6):2322-2336. PubMed ID: 29258089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p38 MAPK-induced MDM2 degradation confers paclitaxel resistance through p53-mediated regulation of EGFR in human lung cancer cells.
    Park SH; Seong MA; Lee HY
    Oncotarget; 2016 Feb; 7(7):8184-99. PubMed ID: 26799187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blocking circ_0010235 suppresses acquired paclitaxel resistance of non-small cell lung cancer by sponging miR-512-5p to modulate FAM83F expression.
    Li Y; Ma Z; Luo M; Liang R
    Anticancer Drugs; 2022 Nov; 33(10):1024-1034. PubMed ID: 36206095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hsa_circ_0092887 targeting miR-490-5p/UBE2T promotes paclitaxel resistance in non-small cell lung cancer.
    Wang L; Zhang Z; Tian H
    J Clin Lab Anal; 2023 Jan; 37(1):e24781. PubMed ID: 36550019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circ_0011292 knockdown mitigates progression and drug resistance in PTX-resistant non-small-cell lung cancer cells by regulating miR-433-3p/CHEK1 axis.
    Jin M; Zhang F; Li Q; Xu R; Liu Y; Zhang Y
    Thorac Cancer; 2022 May; 13(9):1276-1288. PubMed ID: 35348291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic Anticancer Activity of Combined Use of Caffeic Acid with Paclitaxel Enhances Apoptosis of Non-Small-Cell Lung Cancer H1299 Cells in Vivo and in Vitro.
    Min J; Shen H; Xi W; Wang Q; Yin L; Zhang Y; Yu Y; Yang Q; Wang ZN
    Cell Physiol Biochem; 2018; 48(4):1433-1442. PubMed ID: 30064123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An EHMT2/NFYA-ALDH2 signaling axis modulates the RAF pathway to regulate paclitaxel resistance in lung cancer.
    Wang W; Wang J; Liu S; Ren Y; Wang J; Liu S; Cui W; Jia L; Tang X; Yang J; Wu C; Wang L
    Mol Cancer; 2022 Apr; 21(1):106. PubMed ID: 35477569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SOX2 regulates paclitaxel resistance of A549 non‑small cell lung cancer cells via promoting transcription of ClC‑3.
    Huang Y; Wang X; Hu R; Pan G; Lin X
    Oncol Rep; 2022 Oct; 48(4):. PubMed ID: 36069232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paclitaxel nanosuspension coated with P-gp inhibitory surfactants: II. Ability to reverse the drug-resistance of H460 human lung cancer cells.
    Gao L; Liu G; Ma J; Wang X; Wang F; Wang H; Sun J
    Colloids Surf B Biointerfaces; 2014 May; 117():122-7. PubMed ID: 24632038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin Suppresses Stemness of Non-Small-Cell Lung Cancer Induced by Paclitaxel through FOXO3a.
    Tang Z; Zhang Y; Yu Z; Luo Z
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38068934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-22 (IL-22) Regulates Apoptosis of Paclitaxel-Resistant Non-Small Cell Lung Cancer Cells Through C-Jun N-Terminal Kinase Signaling Pathway.
    Li C; Zhao X; Yang Y; Liu S; Liu Y; Li X
    Med Sci Monit; 2018 May; 24():2750-2757. PubMed ID: 29723165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.